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Abstract      : 
 Myoma is a benign neoplasm originated from connective tissues of the uterine smooth muscle. Based 
on an autopsy, Novak revealed that 27% of 25 aged year women had myoma nests, with a higher prevalence in 
dark skinned subjects. Uterine myomas have never been reported before menarche, whereas only 10% cases of 
myomas still develop after menopause. Uterine myomas occur approximately in 20% - 30% of women. In 
Indonesia, uterine myomas constitute 2,39% - 11,7% of all hospitalized gynecology patients. This tumor is 
frequently found in subjects aged 35-45 years old (less than 25%) and is less frequently experianced by 20 year 
aged women and post menopausal women.. 
 A widely excepted opinion indicated that 50% of women with fibroids are completely asymptomatic, 
where as 30% may present with menorrhagia, with the remaining 20% presented with symptoms caused by 
supressions, that complicate reproductive assesments. Whether a fibroid is symptomatic or not possibly depends 
on the size, amount and anatomical site. Sub mucosal myomas may cause menstrual disorders, such as 
menorrhagia and intermenstrual bleeding. Due to its nature that distorts the uterine cavity, myomas may cause 
infertility and/or misscariages.  
 Based on these statistics, the author further ellaborated the association between Myoma and infertility, 
specifically myoma as a causative factor. This paper emphasizes on the causative relationship myoma has with 
infertility, not on the various approaches availabe to treat such cases. 
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Introduction  
 Myoma is a benign neoplasm originated from connective tissues of the uterine smooth muscle (Nassera, 
2004; Hee, 2010; Saravelos, 2011). Based on an autopsy, Novak revealed that 27% of 25 aged year women had 
myoma nests, with a higher prevalence in dark skinned subjects. Uterine myomas have never been reported 
before menarche, whereas only 10% cases of myomas still develop after menopause. Uterine myomas occur 
approximately in 20% - 30% of women. In Indonesia, uterine myomas constitute 2,39% - 11,7% of all 
hospitalized gynecology patients. This tumor is frequently found in subjects aged 35-45 years old (less than 25%) 
and is less frequently experianced by 20 year aged women and post menopausal women..   
Myoma is a monoclone with each tumor considered as a product of single cell replication. The etiology 
proposed include the development of uterine muscle cells or arteries, that originate from metaplastic connective 
tissue transformations, and from persistant residual embryonic cells. Although a current study has identified a 
small amount of genes within the connective that undergo mutations, this does not apply in normal myometrial 
cells. A study has revealed that 40% of subjects were observed with chromosomal abberations specifically at the 
t(12;14)(q15;q24) arm.   
 Several available evidence indicate an increase in progesterone receptors, epidermal growth factor and 
insulin-like growth factor 1 production stimulated by estrogen. Anderson et al has demonstrated that the 
emergence of estrogen stimulated gene are higher in cases of myoma compared to the normal myometrium and 
may play an important role in the development of a myoma.  
 
Classification 
Myomas can be classified based on the affected location and uterine layers. 
1. Location 
x Cervical (2,6%), generally grow towards the vagina causing infections 
x Isthmica (7,2%), frequently cause pain and urinary tract disturbances 
x Corporal (9,1%), the most common affected location, and frequently asymptomatic.  
2. Uterine layer 
 The uterine myoma located on the corpus region, is classified in to the 3 following types based on 
anatomical site.  
x Sub mucosal uterine myoma  
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 Sub mucosal uterine myomas are clinically more significant compared to the remaining types. 
Although sub serosal or intramural uterine myomas are enlarged, these types are frequently 
asymtomatic. Likewise although sub mucosal myomas are small sized, it is frequently characterized by 
vaginal bleeding. The bleeding is frequently difficult to stop, eventually resulting in a hysterectomy.  
x Sub serosal uterine myomas. This type is located adjacently to the uterine corpus subserous layer, 
usually presented as a simple bump or as a single mass connected to the uterus with a rod. Growth may 
be laterally directed towards the latum ligament known as an intraligamenter myoma.  
x Intramural uterine myomas 
Also known as intraepithelial myomas. This type is usually multiple, causing no effects on uterine 
shape when presented as a small group, but would result in an irreguler uterine shape if enlarged, 
consequently causing an increased uterine size and shape. This type is frequently asymptomatic except 
for minor signs that include mild lower abdominal discomfort. Occasionally they grow to form 
subserousal myomas and less frequently into sub mucosal myomas. 
 
Symptoms 
Due to the none interfering nature of this type, nearly half the cases of uterine myomas were discovered 
by coincidence during routine gynaecological examinations. Symptoms highly depend on the anatomical site of 
myomas (cervix, intramural, sub mucosal, subserousal), size, and coexisting changes and complications. The 
symptoms are usually presented as follows : 
1. Abnormal bleeding, disorders that generally occur include hypermenorrhea, menorrhagia and 
   occasionally metrorrhagia.  
2. Pain 
 Pain is not a typical symptom but may occur due to blood circulating disorders in the myoma 
nest, accompanied by local necrosis and inflammation. On extracting sub mucosal myomas, myoma 
growth would narrow the cervical canal causing dysmennorrhea 
3. Symptoms and signs of supression 
 These disorders depend on the size and location of the uterine myoma. Bladder suppression 
would cause polyuria; urethral suprresion would subsequently result in urinary retension, hydro 
urether, and hydronephrosis; rectal suppression may result in obstipation and tenesmus; whereas 
vascular and pelvic lymphatic supresion may cause limb edema and pelvic pain. 
4. Infertility and abortion  
 Infertility may accour as a result of myomas nest closure or intertitial tubal supression, 
whereas sub mucosal myomas may facilitate an abortion due to the presence of a distorted uterine 
cavity. Rubin 1958 states that if all other causes of infertility have been excluded leaving myoma as 
the single cause of infertility, then a myomectomy is indicated.  
 
Diagnosis 
1. History taking 
     A history taking is conducted to detemine the chief complaint together with other clinical symptoms, risk 
factors, and other possible complications. 
2. Physical examination.  
     Local examinations are conducted by palpating the abdomen. The uterine myoma maybe predicted by an 
external physical examination presented as a solid tumor, irregularly shaped, highly mobile with no pain on 
examination.  
a. Transabdominal and transvaginal sonography is usually useful in determining the presence of a 
uterine myoma. Uterine myoma typically produce a sonographic enlargement image with irregular 
borders. 
b. Laparscopic examination, which are highly beneficial to diagnose a smile sized uterine myoma 
due to the direct acces it provides.  
c. Urography, usually performed in cases of sub serosal, intra ligamenter, and cervical myomas, is 
used to determine the ureter anatomical site if myoma supressions were to take place. 
d. Diagnostic histerescopy, that facilitate a direct visualization of the uterine cavity, is used to 
diagnose structural abnormalities. In cases of sub mucosal myoma, histerescopy is the best 
diagnosis method to use. 
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e. MRI (Magnestic Resonanse Imaging) is highly accurate in describing the amount and location of 
myomas, although it is rarely required. In an MRI, a myoma is visualized as a dark, well bordered 
 mass clearly differentiable from the normal myometrium. MRI examinations maybe used as an 
alternative for ultrasonographic imaging in inconclusive cases. 
 The main issue associated with reproduction is whether myomas can cause infertility, misscarriages, 
late pregnancy complications, such as premature delivery, complications during delivery that include 
malpresentations, delivery, dysfunctional uterine contractions, post partum complications that include bleeding, 
sepsis and uterine involution failure. 
 A widely excepted opinion indicated that 50% of women with fibroids are completely asymptomatic, 
where as 30% may present with menorrhagia, with the remaining 20% presented with symptoms caused by 
supressions, that complicate reproductive assesments. Whether a fibroid is symptomatic or not possibly depends 
on the size, amount and anatomical site. Sub mucosal myomas may cause menstrual disorders, such as 
menorrhagia and intermenstrual bleeding. Due to its nature that distorts the uterine cavity, myomas may cause 
infertility and/or misscariages. The effects of intramural fibroids highly depend on the size, the more enlarged 
the fibroid becomes, the more symptoms it produces. Although the anatomical site is essential, a large myoma 
located in the lower uterine segment tends to complicate delivery. 
 Sub serosal myoma is the most least symptomatic myoma although it may cause pain due to a torsioned 
pedinculum (Palomba, 2007; Neelanjana, 2009; Pritt, 2009; Sotirios et al, 2011). 
 Whether or not myomas cause infertility is still debateble. Various studies state that 5-10% of infertile 
women are observed with myomas, however only 2% - 3% are considered to cause infertility. A study reported 
that the insidence of myomas in unexplained cases of infertility is approximately 1% - 2,4%. Theoretically 
myomas alter fertility through various mechanisms. Myomas may also affect gamet transportation by obstructing 
the tubal ostium. Uterine enlargement and uterine contour distortion may affect implantation, uterine 
contractility, and eventually interrupt sperm cell migration and ovum transportation that depend on the size, 
amount and location. Until now, no prospective studies are available to compare fertility rates in a healthy 
women with or without a fibroid, a study of which would be difficult to design. Most of the data presented here 
are obtained from an indirect visualization of fibroid effects on reproductive outcomes. The results were 
frequently conflicting. One study compared pregnancy rates in fertile women with fibroids to women without 
fibroids, after previoulsy excluding male and tubal factors, with a significant negative effect (fertility level of 11 % 
in women with myomacompared to 25 % in subject without a myoma). Uterine myomas affected 0.1-3.9% of 
pregnancies, with a number of complications presented during the antenatal and puerperium periode considered 
to be directly associated with the presence of a benign tumor (Naserra, 2004; Ardhana, 2008).        
 
Pathophysiology: How Uterine Myomas Cause Infertility 
 Although several studies have assesed the correlation between uterine myomas and infertility, the 
mechanism in which uterine myomas adversely affect reproductive functions still remains unknown. However, 
several theories have been proposed, including the list within the table below.  
 
Table 1. Postulated mechanisms by which fibroids cause subfertility (Pritt 2009) 
 
 
 
 
 
 
 
 
 
 
 
 
x A theory has stated that a myoma associated-hyperestrogenic enviroment may cause pathological changes, 
such as subfertility 
x Endometrial cavity contour distortion. Endometrial space distortion may reduce the level of implantation, 
which in this matter, the myoma anatomical location is a determining factor. A Sub mucosal myoma, located 
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adjacent to the internal cervical ostium, may prevent sperm from migrating to the uterine cavity and ovarian 
duct.   
x When located near the cornual edge, an intramural or sub mucosal myoma may block sperm cells from 
migrating into the ovarian duct. Apart from which, myomas are adjacently located to the uterine cornuate, 
may cause fallopian tube distortion, narrowing or kinking due to pressure, contributing to the occurence of 
tubal constriction in the presence or absence of hydrosalphynx. Due to the presence of an enlarged uterine 
space, the distance in which sperm cells must undergo also increases. 
x Dysfunctional uterine contractility is considered responsible for any disturbances that occur during normal 
sperm cell, ovum and embryonal transportation, which eventually interferes with the fertilizing process. 
x Several events in the endometrium that include endometrial atrophy, gland distortion, and endometrial vein 
dilation and ulceration are involved in a mechanism that causes implantation failure. Deligdish and 
Lowenthal in 1970 described a prolonged gland atrophy and distorted period in myoma's anatomical site. 
They also presented evidence of adenomyosis and endometrial basal shedding and muscle fiber separation 
obtained from a subject undergoing curettage. Environmental changes due to myoma-excreted-hormones 
within the uterine cavity is considered a determining cause of substantial myoma changes, eventually 
creating an inappropriate environment for the embryo. Vasoactive amino secretion, local inflammatory 
changes and endometrial androgen-excreted hormones, may occur together due to the presence of the uterine 
myoma, resulting in an interrupted implantation process. 
x Abnormal uterine vascularization. Myomas may also cause infertility by interrupting the endometrial blood 
supply, consequently resulting in a negative impact on the normal implantation process. 
x Chronic endometrial inflammation. All of the above eventually result in a local inflammatory process caused 
by sub mucosal fibroid ulcers responsible in transforming a normal biochemical endometrial environment. 
This process possibly occurs in order to establish an inappropriate environment for sperm cells, 
consequently reducing reproductive potency. 
However, studies evaluating the impact of sub mucosal, intramural and sub serosal fibroids on 
infertility have produced conflicting results. Generally, sub mucosal fibroids, and into a lower extent, 
intramural fibroids, are predicted to negatively affect infertility, especially in terms of pregnancies and 
implantation, whereas sub serosal myomas are considered to have an insignificant effect, if not at all, on 
fertility. 
 
Effects of uterine myomas, based on amount, site, and size on infertility 
In 95% of cases with corpus localized myomas, several knots are usually present. Presence of a myoma is 
associated with fertility issues. Several studies have been conducted to determine the correlation between 
fibroids and infertility. Unfortunately, a definitive conclusion concerning this matter has yet to be determined. 
Also, the myoma's anatomical site is considered an important element to determine the degree of infertility. The 
following anatomical site represents the degree of infertility in a descending sequence: sub mucosal, intramural 
and sub serosal. The current available data concerning different impact caused by sub mucosal, intramural and 
sub serosal myomas on infertility seem to be somewhat confusing and could potentially raise scientific debates. 
The latest medical opinion states that sub mucosal myoma may cause different degrees of infertility in 
each study that was conducted. For example, Richards et al stated that a local inflammatory process may cause 
ulcerations due to the presence of slime that could eventually alter intrauterine biochemical characteristics, 
producing an inappropriate environment for spermatozoas. In addition to this fact, sub mucosal fibroids may 
interrupt endometrial blood supply, consequently affecting the embryonal implantation process. In a controlled 
study, an evaluation was conducted to determine whether the myoma's anatomical site could affect a woman's 
reproductive function and whether extracting myomas prior to implantation could increase pregnancy rates and 
preserve the survival of an ongoing pregnancy. Most of the results obtained from this study indicates an 
increased degree of infertility after an intervention was applied. 
Myomas are not a rare phenomenon observed in women with reproductive issues. Even though a 
substantial amount of evidence support the negative effect of sub mucosal myomas distorting the endometrial 
cavity of a conceptual product (Pritts et al, 2009), this does not apply to women with a diagnosed intramural 
myoma. Until now, the possible effect of myomas on the reproductive product is still debated. It is not surprising 
then if controversy emerges concerning whether or not an intramural fibroid extraction would be effective to 
increase reproductive function. Until now, 2 meta-analysis concerning intramural fibroids, state that this fibroid 
type may negatively affect pregnancies and cause miscarriages (Pritts et al, 2009).  
Considering the cumulative effect of a fibroid, it is advisable to evaluate its impact on fertility based on 
the anatomical site. Previously presented preliminary data state that myomas are frequently located in the sub 
mucosal region. Also, previous several studies have stated that all women are observed with intracavity 
Journal of Natural Sciences Research                                                                                                 www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.3, No.4, 2013 
 
99 
distortion, whereas current studies have concluded that women with myomas are presented with an undistorted 
space. Women with a sub mucosal fibroid, compared to infertile women without fibroid, are presented with a 
significantly decreased pregnancy rate, implantation rate, and ongoing pregnancy/ live birth rate, with a 
significantly increased abortion rate. No significant difference was observed in cases of prematurity. Women 
without any cavity disturbances are usually presented with significantly decreased implantation levels and 
pregnancy survival / live birth rates with an increased spontaneous abortion rate compared to control subjects. 
To conclude, sub mucosal myomas seem to reduce fertility rates, however the presented data above are 
also observed in an undistorted uterine cavity. It seems advisable to subsequently evaluate this condition due to 
its location that affect fertility rate.  
No significant difference was observed for each myoma measurement after comparing a group of women 
with sub serosal myomas with women without myoma. On the contrary women with intra mural myomas are 
usually presented with a significantly lower pregnancy rate, implantation rate, and ongoing pregnancy rate/ life 
birth rate with a significantly higher spontaneous abortion rate. After conducting a limited analysis on this study, 
using a high quality method to access the uterine cavity space, only implantation rates prevailed statistical 
significance. 
 Several studies have compared results of in vitro fertilization (IBF) in women with and without myomas. 
Some of these studies have reported reduced pregnancy rates in patients with a distorted uterine space compared 
to subjects without distortion and myomas (9% vs.. 29, 1% vs.. 25, 1 %, respectively). Other studies have 
showed that sub mucosal and intramural myomas affect implantation and pregnancy rate compared to women 
without fibroids (pregnancy rate 10% vs. 16,4% vs. 30% respectively), where as sub serosal fibroids have no 
such effect on pregnancy (Pritts et al, 2009 ).  
 The following table describes the effects of myoma based on its anatomical site. (Casini et al, 2006) 
 
Table 2. Effect of fibroid location and treatment on pregnancy rates (Casini et al, 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The table above describes that myoma anatomical site, significantly affects fertility states and 
pregnancy preservation rates, according to this following descending order: sub mucosal, intramural and sub 
serosal.  
Another study also states the effects of myomas that include size and anatomical site on infertility, as 
described in the following table. 
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Table 3.Description of the fibroid group (Oliveira, 2004) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Effect of operative measures on myoma on infertility 
The definitive treatment in cases of myomas is to conduct a surgical procedure, but determining the 
time and method to treat myoma still remains debatable. The following diagram describes the steps in 
approaching cases of myoma. 
Myoma extraction is considered a beneficial procedure, where subjects who have undergone 
myomectomy are expected to recover with a higher pregnancy rate and a lower pregnancy rate compare to 
subjects with an unextracted fibroid. 
In patients with sub mucosal myomas, subjects who have undergone surgical procedures are presented 
with a higher pregnancy rate but with a statistically insignificant ongoing pregnancy rate/live birth rate. 
Spontaneous abortion rates showed no significant changes. In women with intramural myomas, no significant 
changes were observed. However, an important note must be taken to underline the fact that these variables have 
not been intensively studied. 
In infertile subjects without fibroids, myomectomy is expected to normalize fertility level compared to 
the control group. This is reflected in women with sub mucosal myomas, observed from: pregnancy rates, 
ongoing pregnancy/live birth rates, spontaneous abortion rates. The statistical conclusion obtained was similar to 
this control group (Pritts et al, 2009). 
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Figure 1. Diagram describing the steps in approaching cases of myoma. (Aradhana, 2008) 
 
The effect of myomectomy in cases of sub mucosal fibroids on fertility is described in the following 
table. The data enlisted are statistically insignificant in terms of increased fertility rates. 
 
Table 4. Sub mucosal fibroids: Effect of myomectomy on fertility. (Pritts, 2009) 
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The effect of myomectomy in cases of intramural myomas on fertility is described in the following table. 
The data enlisted are statistically insignificant in terms of increased fertility rates. 
 
Table 5. Intra mural fibroids (fibroids in situ controls): Effects of myomectomy on fertility (Pritts, 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
Subjects who have undergone myomectomy were observed with a higher pregnancy rate compared to 
untreated subjects (42% vs. 25%). (Bulletti et al 1999). 
The following table is a recapitulation of studies that describes the effect of myomectomy on infertility 
in terms of reproductive outcome. (Neelanjana 2007, Aradhana & Mary 2008, Metwally et al 2010). 
 
The role of laparotomy using myomectomy and laparoscopy using myomectomy in increasing fertility 
 
Table 6. Impact of myomectomy, in case of infertility, on reproductive outcomes (Metwally et al, 2010). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The table above describes post laparatomy myomectomy pregnancy rates reported in average 54% - 
78.9% of cases with a 12% - 22% miscarriage rate. Based on several studies previously published, myomectomy 
is generally perceived as a method to increase conceptual products and pregnancy rates. Until now the most 
optimal results were obtained from young aged subjects with a single fibroid. Myomectomy using a laparotomy 
approach should be the main choice in cases of large sub serosal fibroids or multiple myomas (more than 5). A 
shorter period of infertility, possibly associated with a younger age in the absence of confounding factors of 
infertility, increases the chances of post operative success. Optimal timing in scheduling a surgical procedure is 
essential to provide opportunity for the patients to conceive one year post operatively. The procedure must 
follow the principals of a microsurgical procedure. Minimal vertical incision must be applied and posterior 
incision must be avoided if possible. This procedure would provide adequate information concerning intra cavity 
space and the possibilities of wound dehiscence in subsequent deliveries. Other obtained results that are 
considered more relevant than previous findings are sub mucosal fibroid detections and the presence of myomas 
suppressing the endometrial space. 
Laparoscopy using myomectomy is one method in treating asymptomatic myomas that are associated 
with infertility. Results from a initial study published by Dubuisson & Faucooniere 2007 states that pregnancy 
rates improve after undergoing myomectomy procedures. Laparoscopy using myomectomy offers a shorter 
hospitalization period, an optimal recovery period, minimal adhesions, less post operative pain, decreased 
bleeding and minimal cosmetic damage compared to conventional approaches. However, it is clear that although 
performed by a trained gynecologist, patients must be strictly selected through a well conducted screening 
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procedure, based on the quantity, size and anatomical site of the myoma. One important matter that should be 
attended to is the post operative surgical scar and its impact on subsequent surgical deliveries. 
Hurst et al in a review of laparoscopy using myomectomy concluded that this procedure is more 
acceptable compared to a more invasive approach, especially in subjects attempting a subsequent pregnancy. 
(Hurst et al 2005). Seracchioli et al studied 514 patients undergoing laparoscopy using myomectomy, 158 of 
which accomplished a successful pregnancy; 27.2% experienced spontaneous abortion with the remaining 2.6% 
found positive for an ectopic pregnancy. Twenty five percent of subjects underwent a vaginal delivery, whereas 
74.5% underwent a cesarean section. No records of uterine rupture were stated in these studies. (Seracchioli et al, 
2006) 
Until now the available data have shown results of reproductive functions after undergoing 
myomectomy procedures using a laparoscopy or laparotomy approach. However, any type of myoma extracted 
using a laparoscopic approach is also extractable using a more invasive procedure, although this does not apply 
in the opposite direction. In cases of 2 or more myomas with the total size comparable to 12 weeks of a pregnant 
uterus, gynecologists are advised to perform a laparatomy, rather than a laparoscopy.   
A randomized controlled trial (n = 109) on various surgical methods to perform myomectomy 
(abdominal vs. laparoscopic myomectomy) concluded no significant difference in pregnancy rates (55.9% with 
abdominal myomectomy vs. 53.6 % using laparoscopic myomectomy) or abortion rates (12% vs. 20%) in 
women with large myomas. A significantly higher post operative fever rate and a prolonged hospitalization 
period were found in subjects who previously underwent an abdominal myomectomy (Seracchioli et al, 2000). 
In a study conducted in 91 infertile women treated with laparoscopic myomectomy, the two year post 
operative spontaneous intrauterine pregnancy events were observed in 44 % subjects. The percentage increases 
up to 70% in the absence of infertility factors associated with myoma and conversely decreases until 32 % in the 
presence of one or more factors associated with myomas. The obtained results showed that fertility rates increase 
in women in subjects who were previously treated using a laparotomy approach for infertility. Especially, if only 
patients without any associated infertility factors are considered, the observed conceptual rate differed slightly 
from the same rate observed in women treated with laparotomy. In a randomized clinical trial by seracchielli et al, 
patients with infertility or at least one myoma measuring more than 4 cm were observed with similar fertility 
rates between laparotomic and laparoscopic groups. The following table compares laparoscopic and laparotomic 
procedures and their affects on fertility on obstetric outcome.  
 
Table 7. Laparoscopic versus abdominal myomectomy: outcome. (Seracchioli et al, 2000) 
 
 
 
 
 
 
 
 
 
 
Role of Myomectomy using Hysteroscopy in Increasing Fertility 
 
Table 8. Sub mucosal fibroids: Reproductive outcome following myomectomy (Metwally et al 2010). 
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Most cases of sub mucosal fibroids may easily be dissected by a transcervical hysteroscopy resection 
with relatively lower morbidity rates compared to other forms of myomectomy. Compared to laparotomy and 
myomectomy, hysteroscopic myomectomy is associated with a low risk of rupture during pregnancy and vaginal 
delivery. Pelvic adhesions, that usually occur after undergoing a conventional myomectomy, is usually 
preventable. In various studies, several authors have reported that sub mucosal myoma resections may cause and 
increase pregnancy rates. 
In a study conducted on 134 infertile women undergoing hysteroscopy and myomectomy using lasers or 
scissors, Ubaldi et al reported a 58.9 % pregnancy rate. Unfortunately, no control group was included in this 
study. Even though, this study concluded that hysteroscopy and myomectomy is a safe and effective procedure in 
increasing fertility (Ubaldi et al, 1995). Ketsz et al reported increased pregnancy rates in women undergoing 
polypectomy and myomectomy using hysteroscopy during routine hysteroscopic examinations to assess intra 
uterine cavity as a parameter of infertility compared to infertile women with a normal intra uterine cavity (Ketsz 
et al, 1998). Bernard et al reported fertility and pregnancy outcome rates after undergoing hysteroscopy and 
myomectomy suitable to the characteristics observed from the association between sub mucosal myomas and 
intramural myomas. Higher pregnancy rates were observed in women with a single sub mucosal myoma 
resection compared to 2 subjects with 2 or more fibroids (P꞊ 0.02). No significant difference was observed in 
pregnancy and births rates based on the size and anatomical site of the sub mucosal myoma involved. Likewise, 
patients with an absent associated intramural myoma were observed with a significantly higher birth rate (P < 
0.03) and a significantly shorter delay in the fertilizing process (P ꞊ 0.05) compared to patients with sub mucosal 
and intramural myomas (3.1 months and 4.8 months respectively). This paper concluded that the apparent 
advantage of hysteroscopy and myomectomy include lower surgical risks, resulting in selecting sub mucosal 
myoma resection as a procedure that could enhance fertility in an infertile women (Bernard et al, 2000).   
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